1. Contact details
Name of organisation
1) Department/Research groupBordeaux Pharmacovigilance Regional Centre
2) Organisation/affiliationBordeaux University Hospital
Short Name in the inventoryCRPV-Bx
Administrative Contact
Title Professor
Last name Salvo
First name Francesco
Address line 1Place Amélie Raba Léon
Address line 2
Address line 3
CityBordeaux
Postcode33000
CountryFrance
Phone number (incl. country code)+33557571560
Alternative phone number
Fax number (incl. country code)
Scientific Contact
Title Dr
Last name Miremont
First name Ghada
Address line 1Place Amélie Raba Léon
Address line 2
Address line 3
CityBordeaux
Postcode33000
CountryFrance
Phone number (incl. country code)+33557571560
Alternative phone number
Fax number (incl. country code)
Alternative Scientific Contact
Title Professor
Last name Pariente
First name Antoine
Address line 1Place Amélie Raba Léon
Address line 2
Address line 3
CityBordeaux
Postcode33000
CountryFrance
Phone number (incl. country code)+33557571560
Alternative phone number
Fax number (incl. country code)
2. Description
The Bordeaux Regional Centre for Pharmacovigilance and Drug Information (CRPV-Bx) was created in 1974. On behalf of the French National Agency of Drugs safety, it is the reference center for the former Aquitaine region and the French Overseas Departments. The population covered is about five and a half million people.
CRPV-Bx prioritary missions : i) identification of adverse drug reactions effects in its territory and at the Bordeaux University Hospital; ii) medical evaluation of adverse drug reactions and transmission to competent authorities; iii) information of health professionals about medicines risks and appropriate drug use.
3. Category
University based
Hospital based
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
No
Statistician
No
Yes
Clinician
No
Yes
Clinical Pharmacologist
Yes
No
Pharmacist
No
Yes
IT specialist
No
Yes
Ethics expertise
Yes
No
Legal expertise
No
Yes
Regulatory expertise
No
Yes
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Disorders of the central nervous system
Geriatrics
Immunological products and vaccines
Infectious diseases
Musculoskeletal and joint diseases
Paediatrics
Psychiatry
Skin disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Meta-Analysis
7. Experience in collecting data directly from individual patients/respondents
None
8. Access to data collection resources
Capacity to conduct face-to-face interviews
No
Electronic data capture systems
Yes
System used:
hospital data warehouse
Interactive voice response systems
No
Call centre
Yes
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
SNDS10
11. Registries established by centre
None
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
Networks registered with ENCePP
ACRPV